| Medical and Health Sciences | Lifetime | 511 | US 278 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 893 | US 309 | 99.79 |
| Nephrology | Lifetime | 13 | US 9 | 99.91 |
| Rheumatology | Lifetime | 67 | US 31 | 99.72 |
| Pathology and Forensic Medicine | Lifetime | 320 | US 153 | 98.81 |
| Nephrology | 2021-2025 | 24 | US 11 | 99.48 |
| Rheumatology | 2021-2025 | 98 | US 28 | 97.78 |
| Alcohol Consumption and Health Effects | Lifetime | 5 | US 4 | 99.80 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 3 | US 3 | 99.86 |
| Case Reports on Hematomas | Lifetime | 2 | US 2 | 99.73 |
| Liver Disease Diagnosis and Treatment | Lifetime | 123 | US 49 | 99.78 |
| Urticaria and Related Conditions | Lifetime | 32 | US 14 | 99.46 |
| Inflammasome and immune disorders | Lifetime | 41 | US 16 | 99.36 |
| Vasculitis and related conditions | Lifetime | 39 | US 16 | 99.34 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 84 | US 30 | 99.58 |
| Systemic Lupus Erythematosus Research | Lifetime | 191 | US 77 | 99.31 |
| Spondyloarthritis Studies and Treatments | Lifetime | 97 | US 25 | 98.87 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 141 | US 54 | 97.81 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 938 | US 377 | 97.73 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 101 | US 30 | 96.22 |
| Diet, Metabolism, and Disease | Lifetime | 713 | US 257 | 96.82 |
| Drug-Induced Ocular Toxicity | Lifetime | 68 | US 37 | 94.66 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 513 | US 136 | 96.22 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 801 | US 213 | 95.34 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 777 | US 293 | 94.91 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 609 | US 141 | 85.57 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 3 | US 1 | 99.27 |
| Drug-Induced Ocular Toxicity | 2021-2025 | 2 | US 1 | 93.76 |
| Case Reports on Hematomas | 2021-2025 | 4 | US 1 | 97.67 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 152 | US 43 | 97.48 |
| Alcohol Consumption and Health Effects | 2021-2025 | 63 | US 26 | 96.77 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 868 | US 180 | 96.30 |
| Urticaria and Related Conditions | 2021-2025 | 235 | US 46 | 91.41 |
| Vasculitis and related conditions | 2021-2025 | 376 | US 60 | 88.38 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 126 | US 20 | 81.30 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 521 | US 105 | 81.81 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 957 | US 120 | 77.24 |
| Potassium and Related Disorders | 2021-2025 | 712 | US 242 | 60.33 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 982 | US 145 | 47.91 |
